glp 1 and kidney stones Renal effects of GLP-1 receptor agonists tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine TrimRX | Can GLP-1 Cause
Description
GLP-1 receptor agonists are transforming diabetes and obesity care
This is promising, but the evidence is observational
The blood glucose reduction level was calculated by dividing the blood glucose concentration by the concentration before insulin treatment
The role of GLP-1 receptor agonists in managing type 2 diabetes
Emerging cardiovascular benefits: Early evidence suggests that GLP-1 micro-dosing may contribute to improved cardiovascular health, reducing inflammation and lowering blood pressure
Reducing appetite: They can help reduce overall food intake, contributing to weight management
